Globus Medical (GMED) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Globus Medical Reports Second Quarter 2018 Results
August 1, 2018 4:15 PM EDTAUDUBON, Pa., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2018.
Worldwide sales were $173.4 million, an increase of 13.8% as reportedSecond quarter net income was $45.0 million, an increase of 56.9%Diluted earnings per share (EPS) and non-GAAP EPS were $0.44Non-GAAP EPS increased 38.0% compared to second quarter of 2017Non-GAAP adjusted EBITDA was 34.3% of sales"The second quarter marks the third consecutive quarter of double-digit organic... More
